1. Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice.
- Author
-
Yuqing Liu, Xiaoqi Wang, Yongping Zhu, Mingfeng Zhang, Nasri, Ubaydah, Sun, Sharne S., Forman, Stephen J., Riggs, Arthur D., Xi Zhang, Defu Zeng, Liu, Yuqing, Wang, Xiaoqi, Zhu, Yongping, Zhang, Mingfeng, Zhang, Xi, and Zeng, Defu
- Subjects
- *
CHIMERISM , *AUTOIMMUNITY , *PEOPLE with diabetes , *AUTOIMMUNE diseases , *T cells , *TREATMENT of diabetes , *RESEARCH , *BONE marrow transplantation , *HOMOGRAFTS , *ANIMAL experimentation , *RESEARCH methodology , *DIABETES , *TYPE 1 diabetes , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *RESEARCH funding , *MICE - Abstract
Clinical trials are currently testing whether induction of haploidentical mixed chimerism (Haplo-MC) induces organ transplantation tolerance. Whether Haplo-MC can be used to treat established autoimmune diseases remains unknown. Here, we show that established autoimmunity in euthymic and adult-thymectomized NOD (H-2g7) mice was cured by induction of Haplo-MC under a non-myeloablative anti-thymocyte globulin-based conditioning regimen and infusion of CD4+ T cell-depleted hematopoietic graft from H-2b/g7 F1 donors that expressed autoimmune-resistant H-2b or from H-2s/g7 F1 donors that expressed autoimmune-susceptible H-2s. The cure was associated with enhanced thymic negative selection, increased thymic Treg (tTreg) production, and anergy or exhaustion of residual host-type autoreactive T cells in the periphery. The peripheral tolerance was accompanied by expansion of donor- and host-type CD62L-Helios+ tTregs as well as host-type Helios-Nrp1+ peripheral Tregs (pTregs) and PD-L1hi plasmacytoid DCs (pDCs). Depletion of donor- or host-type Tregs led to reduction of host-type PD-L1hi pDCs and recurrence of autoimmunity, whereas PD-L1 deficiency in host-type DCs led to reduction of host-type pDCs and Helios-Nrp1+ pTregs. Thus, induction of Haplo-MC reestablished both central and peripheral tolerance through mechanisms that depend on allo-MHC+ donor-type DCs, PD-L1hi host-type DCs, and the generation and persistence of donor- and host-type tTregs and pTregs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF